chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever; chills; vomiting; headache; This is a spontaneous report from a contactable consumer. A male patient of unknown age received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19.It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 14Apr2021,the patient experienced fever, chills, vomiting and headache. It was unknown whether therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, vomiting and headache was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Out of nowhere I started having heart palpitations which were later diagnosed as PVCs, PACs, and SVTs.
?Moderna arm?, or rash on upper arm around injection site. Discovered about 36 hours after injection, but may have appeared as early as several hours before
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 11-MAR-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml, (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 48 hours with the lowest recorded temperature of 32 Fahrenheit degree. The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Fever, red bumps on face, arms and stomach. Fever that night. Bumps start a day later.
This spontaneous report was received from nurse and refers to a 7 month old female patient. The patient's medical history, concurrent conditions and allergies were not reported. On 24-SEP-2015, the patient was inadvertently vaccinated with a dose of PNEUMOVAX23 (lot # K020214 with expiration date: 25-MAR-2016), (strength dose, route and anatomical location were not reported), which is an inappropriate schedule of drug administration as the patient age was less than 2 years. Other suspect and concomitant therapies were not reported. No adverse  events were reported. Additional information has been requested.
Significant tinnitus in my right ear (started yesterday, 10 days after my first vaccination).
Extreme shoulder pain, hoarseness, fever, aches, headache, itching, fatigue. Fifth day.
fast heartbeat; Boredom; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 83-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date: unknown), via an unspecified route of administration on 07Mar2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 07Mar2021, the patient experienced following symptoms fast heartbeat, boredom and fatigue. The patient underwent lab tests and procedures which included heart rate: fast on an unknown date. Outcome of events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
No additional AEs were reported; The healthcare worker reported that a patient received improperly stored vaccine.  The patient received only one dose but the healthcare worker did not specify which actual lot the patient received the vaccine.  No additional AEs were reported, no fu; This spontaneous report was received from a healthcare worker and refers to a 2-year-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 31-AUG-2022, the patient was vaccinated with one dose of hepatitis a vaccine, inactivated (VAQTA) prefilled syringe, intramuscular injection, lot number and expiration date were reported to be either W003118 and 13-JUL-2023 or W015191 (lot number confirmed to be valid for formulation prefilled syringe) and 27-OCT-2023, respectively (the reporter did not specify which lot number was administered to the patient) for prophylaxis (dose, strength, and route of administration were not provided). The vaccine was improperly stored (temperature: 11.3 Celsius degrees, time frame: 34 minutes, no previous temperature excursion) (product storage error). No additional adverse event was reported (no adverse event).
Case previously recorded as MA2009-3696. Initial case report received from a nurse via MedCom on 04 NOV 2009. A patient 1-year-old male was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no. 102041P1) once i.m. on 04 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-007553.
it may be due to a delayed hypersensitivity reaction to a component in the vaccine, active or inactive; maculopapular lesions right around the injection site; This is a spontaneous report from a contactable physician (allergist). A 5-month-old patient of an unspecified gender received the first dose of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. This allergist reported that the patient received an initial dose of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) and experienced maculopapular lesions right around the injection site. The physician who administered the injection felt it may be due to a delayed hypersensitivity reaction to a component in the vaccine, active or inactive, and the patient was referred to the allergist for possible patch testing and further evaluation. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Tiredness, joint pain, severe stomach and intestinal pain, tightness in chest, nausea and vomiting, labored breathing
Getting out of breath; COVID-19 Vaccine Booster - Tested Positive for COVID; This spontaneous case was reported by a patient and describes the occurrence of DYSPNOEA (Getting out of breath) and COVID-19 (COVID-19 Vaccine Booster - Tested Positive for COVID) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056AZZA, 041C21A, 016M20A and 011L20A) for COVID-19 prophylaxis.     Concurrent medical conditions included Asthma (Asthma Diagnosed 40 years ago) and Blood pressure high. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) from an unknown date to 16-Oct-2022 for Asthma, AMLODIPINE from 01-Oct-2022 to an unknown date for Blood pressure high.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Getting out of breath) and COVID-19 (COVID-19 Vaccine Booster - Tested Positive for COVID). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) ongoing from 15-Oct-2022 for COVID-19, at an unspecified dose and frequency; NIRMATRELVIR on 15-Oct-2022 at a dose of 300 milligram, 2 Nirmatrelvir at a time and RITONAVIR on 15-Oct-2022 at a dose of 100 milligram,1 Ritonavir at a time. At the time of the report, DYSPNOEA (Getting out of breath) and COVID-19 (COVID-19 Vaccine Booster - Tested Positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.         Patient was getting out of breath: started before Paxlovid. Doesn't happen unless patient had an asthma attack. She must had omicron variant.
Sleepy; Tired; Dizzy; skin burning sensation through out body; Pain spread from left arm to right arm; Both legs cramping; My face turn red flushed with headache; Rapid and strong heartbeats; Some short of breathe; Anxiety; FACE TURN RED FLUSHED WITH HEADACHE; This is a spontaneous report from a contactable healthcare professional, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0169) via an unspecified route of administration in the left arm on 20Apr2021 at 08:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS) and adenoma. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication taken within two weeks were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 30Mar2021 at 08:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 21:15, the patient initially once she got vaccine she began sleepy, tired, and dizzy 12-13 hours after vaccine. Also experienced skin burning sensation through out body, pain spread from left arm to right arm down both legs cramping. The patient's face turned red flushed with headache with very rapid and strong heartbeats. Some short of breathe and top of it anxiety same time. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department visit or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sleepy, tiredness, dizzy, burning sensation skin, pain spread from left arm to right arm down both legs cramping patient's face turned red flushed with headache with very rapid and strong heartbeats, some short of breathe and top of it anxiety was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Received DTaP to left thigh during 4 yo PE on 5/10/06. Started having a vaccine reaction that night which became enlarged reddened and hard on the left thigh.
(L) arm swelling, redness, pain, bodily aches. 2 1/2 x 3" circular region of the deltoid, hot to touch.
headache; arm pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 28-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 18Dec2020 09:30 at a single dose on left arm for COVID-19 immunization. Medical history included Postural orthostatic tachycardia syndrome. Concomitant medication included spironolactone and metoprolol. The patient experienced headache and arm pain on an unspecified date after first dose (reported as "First dose: headache, arm pain"). No treatment received for adverse events. The outcome of the events was recovering. The events were assessed as non-serious. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Information on the lot/ batch number has been requested.
Noted redness and inflammation at inj site with two small red, somewhat blistered, raised areas. Noted on 06/23/02. No other symptoms associated. Comfort measures recommended.
six of the patients developed shingles within several days of receiving the vaccine; This is a spontaneous report from a contactable consumer. The consumer reported similar events for 6 patients including her daughter. This is the 5th of the six reports. A female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: unknown and Expire Date: unknown) via unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After vaccination patient experienced herpes zoster on an unspecified date.  The researchers found that six of the patients developed shingles within several days of receiving the vaccine. All of the patients were women, and five of the reactions happened after the first vaccine dose. The Clinic also said that it's triggered by the same virus that causes chickenpox. Caller is asking if she should take a Shingles shot before getting the vaccine. Caller is surprised that we don't have any data on shingles or herpes since the Pfizer-BioNTech COVID-19 Vaccine was linked in the article and people have reported these and her daughter also experienced it. The outcome of event was unknown.   Information on the lot/batch number has been requested.
Patient received first Moderna Covid 19 vaccine on 12/29/2020. The next morning, she had headache, fever, chills,, cough myalgia, dyspnea.  Diagnosed positive COVID 19 by her physician. on 1/4/202.  On  1/07/2021, she developed rash on her chest.  Seen by her physician and diagnosed with shingles.  It appears that she was asymptomatic but positive for  Covid 19 at time of first dose of Covid 19 vaccine.  She went on to get her second Covid 19  vaccination on 1/26/2021.  She developed transient low grade fever, chills, nausea and diarrhea. She has returned to work is is symptom free.
30 min. after injection pt. became pale and nauseated. She then vomitted, became dizzy and shakey. She was given ZOFRAN for nausea and symptoms subsided with rest.
This spontaneous report as received from a female patient of unknown age reporting herself. On unknown date the patient was vaccinated with two doses of VARIVAX (Merck) respectively (date, dose, route and lot number not provided). These two doses were administered eight years apart. And the titer results had been "equivocal" after each administration. The outcome the event was unknown. Additional information is not expected.
Covid-19; Stomach upset; Diarrhea; Severe back pain; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), ABDOMINAL DISCOMFORT (Stomach upset), DIARRHOEA (Diarrhea) and BACK PAIN (Severe back pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced COVID-19 (Covid-19), ABDOMINAL DISCOMFORT (Stomach upset), DIARRHOEA (Diarrhea) and BACK PAIN (Severe back pain). At the time of the report, COVID-19 (Covid-19), ABDOMINAL DISCOMFORT (Stomach upset), DIARRHOEA (Diarrhea) and BACK PAIN (Severe back pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included blood pressure medication.  The patient took paracetamol as treatment medication for the reported events.  Patient experienced delayed symptoms after the first dose of vaccine.   This case was linked to MOD-2021-060741 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Followup information received on 13-May-2021 and Updated the event outcome from unknown to recovered for all the reported events. Added the information the patient denied to provide email address/fax.
Pt. received 0.5 ML IM L deltoid of J&J COVID19 vaccine and ambulated independently to observation area. While in observation area pt. became lightheaded, dizzy, and flush and slipped out of his chair to his hands and knees. Bystander helped pt to the floor so he did not hit his head. BP immediately was 118/74, no blurry vision, no headache, no nausea, had not eaten since 1300. Pt sat up and vitals were taken: BP 126/82 HR80 RR18 A/Ox4, pupils equal and reactive. Pt was then assisted to the cot where he had a snack and juice and was feeling much better. Pt called a friend to drive him home.
This spontaneous report as received from medical assistant via a physician refers to a unspecified amount of patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant medications were not reported. On an unknown date the patient were vaccinated with improperly stored LIQUID PEDVAXHIB (lot N007749, expiration date 29-NOV-2019; lot N003700, expiration date 01-NOV-2019)(incorrect product storage) for prophylaxis. Temperature was reported as 47°F to 77°F and Time frame was reported as 2 Hours 30 Minutes. Previous temperature excursion was involved. The call was because of a "data logger".  No adverse effects reported. No PQC involved. No further details provided. This is one of the several reports linked via same reporter link.; Sender's Comments: US-009507513-1708USA005419: US-009507513-1708USA006276:
I had chills all night and the next morning I collapsed to the floor while urinating. My wife called the ambulance and I went to the ER and was given fluids and they sent me home. I felt better after getting some fluids. I saw my primary doctor about a week later.
12 hours after the shot I got chills, then started running fever for 24 hours- highest being 102.1.  By 24 hour after the shot I had fever, chills, nauseated, dizzy, and bad headache. By 36 hour after the shot I felt fine other than a persistent headache that lasted 5 days. I also developed what I would call brain fog days 3 through 5 after the shot. I coukd not say the words I wanted to say or think clearly. 5 days after the shot everything was back to normal. I NEVER get sick, I have not missed a day of work in 9 years and had to call in sick the day after the shot because I was so dizzy and sick to my stomach.
Moderna COVID-19 Vaccine EUA Sore right arm at injection site, headache and muscle aches
Pt was given DTP in the morning by 3PM devel t106; convuls, sent home came back same day w/2nd convuls; sent home came back w/3rd convulsion; questionable otitis;
Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Medium, Additional Details: Patient was administered vaccine per protocol. Prior to injection patient was complaining of being nervous, and permission was sought to proceed with the shot. Patient fainted about 10 seconds after the completion of the injection and was stabilized in the chair. When the patient came to she was complaining of nausea and proceeded to vomit several times. Mother of the patient was present at the time and said that she had a crippling fear of needles.
Dose was administered >12 hours after vial puncture (expired). / HCP accidentally gave an expired dose to a patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose was administered >12 hours after vial puncture (expired). / HCP accidentally gave an expired dose to a patient) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jul-2021 at 10:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was administered >12 hours after vial puncture (expired). / HCP accidentally gave an expired dose to a patient). On 28-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Dose was administered >12 hours after vial puncture (expired). / HCP accidentally gave an expired dose to a patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  On 27-Jul-2021 the vial was removed from the refrigerator and needle punctured around 19:00 and then stored at room temperature.
Facial rash following administration of MMR, DTaP and IPV on 01/27/17. No changes in diet or products.
Patient stated on Jan 16, 2010, she noticed while at home a few small red bumps on side of left arm close to body, between wrist and elbow. She stated on Jan. 19, 2010 she noticed more bumps on her chest and back area. She went to ER at hosp. Doctor gave her BENADRYL and a "steroid" to take. She doesn't remember name of steroid. The doctor gave her a referral to an allergist to determine if bumps were a reaction to vaccine. She already made an appt. to go in March 2010.
Husband is having the side effect of severe aches after his 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Husband is having the side effect of severe aches after his 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Husband is having the side effect of severe aches after his 2nd dose). At the time of the report, PAIN (Husband is having the side effect of severe aches after his 2nd dose) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
On 02/10/2022 I had vaccination. On 08/22/2022 I started with a scratchy throat and a little bit of a cough. I thought it was because I had taught that morning but it persisted. I had a headache. I took an at home test that evening and it was negative. I took another test the morning of 08/23/2022 and it was COVID-19 positive. I started on Plaxovid on 08/22/2022.
Narrative: 56-year-old male presents emergency room complaining of tightness in his throat and rash. Patient had his first COVID vaccine yesterday. States he "felt bad" last night when he went to bed. Woke this morning feeling some tightness in his throat and covered with a red rash. Some itchiness to the rash. No similar episodes with vaccines in the past. Pt was treated in the ER with IV Pepcid, IV Benadryl & IV Solumedrol. Pt ordered Rxs for oral prednisone, oral famotidine oral diphenhydramine.
Patient came into clinic and requested Pfizer Covid-19 vaccine. She stated that she had discussed it with her PCP, and even though she had received Janssen Covid-19 vaccine 4/2/21 she wanted to get the vaccine.
Difficulty breathing, stridor, barking cough, tiny amount of throwing up (I think from the intense coughing).
Powder was mixed with generic sterile diluent (used for Varicella and/or Proquad) instead of the provided diluent.
Approximately 11 hours after receiving vaccine developed chills,fever,headache,bodyaches,arm pain